This federal contract award, with an ID of SPE2DB22D2108|SPE2DB25FU2WT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,765.23 Firm Fixed Price Delivery Order contract is for the supply of the Advair HFA 230-21 MCG Inhaler, a pharmaceutical product used for the treatment of respiratory conditions. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. The place of performance is Conshohocken, Pennsylvania. This contract award is not designated as a set-aside. It is a child contract associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/10/25, 9:43 AM